- Phare
- Validé par KD/KO
Anticorps Monoclonal anti-CXCL16
CXCL16 Monoclonal Antibody for WB,ELISA
Hôte / Isotype
Mouse / IgG2a
Réactivité testée
Humain, souris et plus (1)
Applications
WB, IHC, IF, ELISA
Conjugaison
Non conjugué
CloneNo.
2H7B3
N° de cat : 60123-1-Ig
Synonymes
Galerie de données de validation
Applications testées
Résultats positifs en WB | cellules SH-SY5Y |
Dilution recommandée
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:200-1:1000 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Applications publiées
KD/KO | See 1 publications below |
WB | See 2 publications below |
IHC | See 1 publications below |
IF | See 1 publications below |
Informations sur le produit
60123-1-Ig cible CXCL16 dans les applications de WB, IHC, IF, ELISA et montre une réactivité avec des échantillons Humain, souris
Réactivité | Humain, souris |
Réactivité citée | rat, Humain, souris |
Hôte / Isotype | Mouse / IgG2a |
Clonalité | Monoclonal |
Type | Anticorps |
Immunogène | CXCL16 Protéine recombinante Ag4883 |
Nom complet | chemokine (C-X-C motif) ligand 16 |
Masse moléculaire calculée | 273 aa, 30 kDa |
Poids moléculaire observé | 35 kDa, 60 kDa |
Numéro d’acquisition GenBank | BC017588 |
Symbole du gène | CXCL16 |
Identification du gène (NCBI) | 58191 |
Conjugaison | Non conjugué |
Forme | Liquide |
Méthode de purification | Précipitation de l'acide caprylique/du sulfate d'ammonium |
Tampon de stockage | PBS avec azoture de sodium à 0,02 % et glycérol à 50 % pH 7,3 |
Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
CXCL16 is a recently discovered cytokine belonging to the CXC chemokine family, which is synthesised in plasmacytoid dendritic cell as a transmembrane molecule. It exists in a transmembrane and soluble form. The transmembrane form of CXCL16 functions as an adhesion molecule for CXCR6-expressing cells, whereas the soluble form of CXCL16 mediates infiltration of circulating cells into sites of injury. CXCL16, has been proposed as an important pathogenic mediator in inflammatory diseases, including rheumatoid arthritis, glomerulonephritis, or prostate cancer. CXCL16 has been implicated in some forms of renal disease such as lupus nephritis and antiglomerular basement membrane nephritis. CXCL16 also plays a pivotal role in the pathogenesis of angiotensin II-induced renal injury and fibrosis through regulation of macrophage and T cell infiltration and bone marrow-derived fibroblast accumulation.
Protocole
Product Specific Protocols | |
---|---|
WB protocol for CXCL16 antibody 60123-1-Ig | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
Publications
Species | Application | Title |
---|---|---|
Cancer Commun (Lond) Activation of Piezo1 contributes to matrix stiffness-induced angiogenesis in hepatocellular carcinoma | ||
FASEB J Pathogenic Tconvs promote inflammatory macrophage polarization through GM-CSF and exacerbate abdominal aortic aneurysm formation. | ||
Mol Med Rep oxLDL promotes podocyte migration by regulating CXCL16, ADAM10 and ACTN4.
| ||
Cardiovasc Diabetol Klotho inhibits renal ox-LDL deposition via IGF-1R/RAC1/OLR1 signaling to ameliorate podocyte injury in diabetic kidney disease |